Skip to content
Inciteful Med

Understanding Hereditary Spherocytosis: The Biology of Red Blood Cells

Last updated:

Hereditary Spherocytosis (HS) is an inherited blood disorder that causes red blood cells to become rigid and spherical. This abnormal shape causes the spleen to prematurely destroy the cells, leading to anemia. With proper management, most people with HS live full, active lives.

Key Takeaways

  • • Hereditary spherocytosis is a genetic blood disorder that causes red blood cells to be spherical and rigid instead of flexible discs.
  • • The abnormal shape of these cells causes them to get trapped and prematurely destroyed by the spleen, resulting in hemolytic anemia.
  • • Mutations in five key genes, most commonly ANK1, are responsible for weakening the structural framework of the red blood cell.
  • • The condition is most frequently inherited when a child receives just one mutated gene from a parent.
  • • Despite being a lifelong genetic condition, the vast majority of individuals diagnosed with hereditary spherocytosis live normal, active lives.

Receiving a diagnosis of Hereditary Spherocytosis (HS) can be overwhelming, especially when it involves the complex biology of the blood. It is natural to feel a sense of shock when learning about a genetic condition [1]. However, it is important to ground yourself in three stabilizing facts: HS is a manageable condition, its severity varies greatly from person to person, and the vast majority of people with HS live full, active, and normal lives [2][3][4].

Hereditary Spherocytosis is the most common cause of inherited hemolytic anemia (a condition where red blood cells are destroyed faster than they can be made) in people of Northern European descent, affecting approximately 1 in 2,000 people [1][5]. While it is also found in other global populations, it is sometimes underreported or mistaken for other blood disorders [6][7].

The Biology of the “Spherocyte”

To understand HS, it helps to look at how a healthy red blood cell works. Normally, these cells are shaped like flexible discs (biconcave discs). This shape gives them a high surface-area-to-volume ratio and allows them to “squish” and deform so they can fit through the tiny capillaries of the circulatory system [8][9].

In HS, a genetic mutation disrupts the proteins that act as the “skeleton” of the cell membrane [10]. Because this internal scaffolding is weak, the cell loses bits of its membrane over time. As the surface area shrinks, the cell is forced into a tight, rigid, spherical shape called a spherocyte [8][11]. Unlike healthy cells, spherocytes cannot flex or fold [8].

The Role of Specific Genes

Five key genes provide the blueprints for the proteins that stabilize the red blood cell membrane. A mutation in any one of these can lead to HS:

  • ANK1 (Ankyrin-1): The most common gene involved; it links the cell’s skeleton to its outer “skin” [12][13].
  • SPTB (Beta-spectrin): Works with Ankyrin to maintain the cell’s structural integrity [14][15].
  • SLC4A1 (Band 3): An essential structural protein that anchors the membrane; mutations here often lead to milder cases [16][17].
  • SPTA1 (Alpha-spectrin): Often associated with more severe, recessive forms of the condition [17][18].
  • EPB42 (Protein 4.2): Another anchoring protein that helps keep the cell membrane stable [16][19].

The Spleen: The Body’s Filter

The primary reason you or your child experiences anemia is not that the body cannot make red blood cells, but because the spleen destroys them prematurely [9][8].

The spleen acts as a quality-control filter for the blood. It contains very narrow passages called sinusoids. Healthy, flexible red blood cells easily slide through these gaps [8]. However, the rigid spherocytes get stuck [9]. Once trapped in the harsh environment of the spleen, these cells are identified as “damaged” and are destroyed by specialized immune cells called macrophages [9][8]. This process of destruction is called hemolysis [9].

How HS is Inherited

Hereditary Spherocytosis is passed down through families in two primary ways:

  1. Autosomal Dominant (75% of cases): This is the most common pattern. A child only needs to inherit one mutated gene from one parent to have the condition [4][20].
  2. Autosomal Recessive and De Novo (25% of cases): In the remaining cases, the condition is either inherited in an autosomal recessive pattern (where a child inherits two copies of the mutated gene, often associated with the SPTA1 or EPB42 genes and resulting in more severe anemia) or there is no family history because the mutation occurred spontaneously (de novo) [21][22][23].

Understanding the specific genetic “blueprint” and inheritance pattern in your family can help your care team predict the likely course of the condition and provide the most effective support [1][11].

Frequently Asked Questions

What causes Hereditary Spherocytosis?
Hereditary spherocytosis is caused by a genetic mutation that affects the structural proteins of the red blood cell. This weakens the cell's outer layer, forcing it to shrink into a tight, rigid sphere instead of maintaining its normal flexible, disc-like shape.
How is Hereditary Spherocytosis inherited?
In about 75% of cases, the condition is inherited from just one parent who carries the mutated gene. In the remaining 25% of cases, it is either passed down from both parents or occurs spontaneously without any family history of the disorder.
Why does the spleen destroy red blood cells in this condition?
The spleen acts as a filter for the blood, containing very narrow passages. Because spherocytes are rigid and cannot bend like healthy cells, they get trapped in these passages and are destroyed by specialized immune cells, which leads to anemia.
Should my family members be tested for Hereditary Spherocytosis?
Since hereditary spherocytosis is a genetic condition, it is often recommended to screen close relatives. Your doctor can help determine who in your family should be tested based on your specific genetic mutation and inheritance pattern.
Can you live a normal life with Hereditary Spherocytosis?
Yes. While the severity of symptoms can vary from person to person, the vast majority of people with hereditary spherocytosis live full, active, and normal lives with appropriate monitoring and management.

Questions for Your Doctor

  • • Which specific gene mutation was identified in my or my child's case, and does it typically suggest a mild, moderate, or severe course?
  • • Based on the inheritance pattern you've identified, should other family members be screened even if they don't have symptoms?
  • • What is the current 'reticulocyte count,' and what does that tell us about how hard the bone marrow is working to replace red blood cells?
  • • Is the spleen currently enlarged (splenomegaly), and how will we monitor its size over time?

Questions for You

  • • Has anyone in my extended family ever been diagnosed with anemia, 'yellow jaundice,' or had their gallbladder or spleen removed at a young age?
  • • How has this diagnosis affected my or my child's daily energy levels and ability to participate in physical activities?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Identification of a Novel Mutation of β-Spectrin in Hereditary Spherocytosis Using Whole Exome Sequencing.

    Bogusławska DM, Skulski M, Machnicka B, et al.

    International journal of molecular sciences 2021; (22(20)) doi:10.3390/ijms222011007.

    PMID: 34681667
  2. 2

    Mild Hereditary Spherocytosis without Accompanying Hereditary Haemochromatosis: An Unrecognised Cause of Iron Overload.

    Tole S, Amid A, Baker J, et al.

    Acta haematologica 2019; (141(4)):256-260 doi:10.1159/000497175.

    PMID: 30965318
  3. 3

    Hereditary Spherocytosis in the Neonatal Period: A Case Report.

    Will A, Henderson CA, Jnah AJ, Newberry D

    Neonatal network : NN 2017; (36(5)):280-288 doi:10.1891/0730-0832.36.5.280.

    PMID: 28847351
  4. 4

    Coexistence of hereditary spherocytosis with SPTB P.Trp1150 gene variant and Gilbert syndrome: A case report and literature review.

    Chi C, Wu S, Zhou W, et al.

    Open life sciences 2024; (19(1)):20220904 doi:10.1515/biol-2022-0904.

    PMID: 38947766
  5. 5

    Novel Variant of the SLC4A1 Gene Associated with Hereditary Spherocytosis.

    Bogusławska DM, Kraszewski S, Skulski M, et al.

    Biomedicines 2023; (11(3)) doi:10.3390/biomedicines11030784.

    PMID: 36979763
  6. 6

    A tetranucleotide deletion in the ANK1 gene causes hereditary spherocytosis; a case of misdiagnosis.

    Zhu F, Liang M, Xu L, et al.

    Gene 2020; (726()):144226 doi:10.1016/j.gene.2019.144226.

    PMID: 31669644
  7. 7

    A 6-Day-Old Male Infant with Severe Hyperbilirubinemia Diagnosed with Hereditary Spherocytosis at a Tertiary Hospital in East Java, Indonesia: A Diagnostic and Management Challenge in a Developing Country.

    Corebima BIRV, Monica C, Sulistijono E, et al.

    The American journal of case reports 2022; (23()):e937416 doi:10.12659/AJCR.937416.

    PMID: 36399434
  8. 8

    An overview of hereditary spherocytosis and the curative effects of splenectomy.

    Turpaev K, Bovt E, Shakhidzhanov S, et al.

    Frontiers in physiology 2025; (16()):1497588 doi:10.3389/fphys.2025.1497588.

    PMID: 40008208
  9. 9

    Membrane Protein Detection and Morphological Analysis of Red Blood Cells in Hereditary Spherocytosis by Confocal Laser Scanning Microscopy.

    Rey-Barroso L, Roldán M, Burgos-Fernández FJ, et al.

    Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada 2023; (29(2)):777-785 doi:10.1093/micmic/ozac055.

    PMID: 37749743
  10. 10

    A previously unrecognized Ankyrin-1 mutation associated with Hereditary Spherocytosis in an Italian family.

    Lazzareschi I, Curatola A, Pedicelli C, et al.

    European journal of haematology 2019; (103(5)):523-526 doi:10.1111/ejh.13311.

    PMID: 31400153
  11. 11

    Novel mutation in alpha-spectrin gene in Saudi patients with hereditary spherocytosis.

    Alshomar A, Ahmed AA, Rasheed Z, et al.

    Nucleosides, nucleotides & nucleic acids 2024; (43(11)):1282-1301 doi:10.1080/15257770.2024.2310703.

    PMID: 38319988
  12. 12

    Identification and functional analysis of novel SPTB and ANK1 mutations in hereditary spherocytosis patients.

    Panarach C, Netsawang C, Nuchprayoon I, Leecharoenkiat K

    Scientific reports 2024; (14(1)):27362 doi:10.1038/s41598-024-78622-w.

    PMID: 39521890
  13. 13

    Targeted next-generation sequencing identifies novel deleterious variants in ANK1 gene causing severe hereditary spherocytosis in Indian patients: expanding the molecular and clinical spectrum.

    More TA, Devendra R, Dongerdiye R, et al.

    Molecular genetics and genomics : MGG 2023; (298(2)):427-439 doi:10.1007/s00438-022-01984-1.

    PMID: 36598564
  14. 14

    Whole exome sequencing identified a novel mutation (p.Ala1884Pro) of β-spectrin in a Chinese family with hereditary spherocytosis.

    Fan LL, Liu JS, Huang H, et al.

    The journal of gene medicine 2019; (21(2-3)):e3073 doi:10.1002/jgm.3073.

    PMID: 30690801
  15. 15

    The new landscape of differentially expression proteins in placenta tissues of gestational diabetes based on iTRAQ proteomics.

    Ge L, Huang P, Miao H, et al.

    Placenta 2023; (131()):36-48 doi:10.1016/j.placenta.2022.11.012.

    PMID: 36473392
  16. 16

    Effect of primary lesions in cytoskeleton proteins on red cell membrane stability in patients with hereditary spherocytosis.

    Vercellati C, Marcello AP, Fattizzo B, et al.

    Frontiers in physiology 2022; (13()):949044 doi:10.3389/fphys.2022.949044.

    PMID: 36035481
  17. 17

    Genotype-phenotype correlation in children with hereditary spherocytosis.

    Tole S, Dhir P, Pugi J, et al.

    British journal of haematology 2020; (191(3)):486-496 doi:10.1111/bjh.16750.

    PMID: 32436265
  18. 18

    Deciphering molecular heterogeneity of Indian families with hereditary spherocytosis using targeted next-generation sequencing: First South Asian study.

    Aggarwal A, Jamwal M, Sharma P, et al.

    British journal of haematology 2020; (188(5)):784-795 doi:10.1111/bjh.16244.

    PMID: 31602632
  19. 19

    Identification of a novel de novo ANK1 R1426* nonsense mutation in a Chinese family with hereditary spherocytosis by NGS.

    Wang X, Yi B, Mu K, et al.

    Oncotarget 2017; (8(57)):96791-96797 doi:10.18632/oncotarget.18243.

    PMID: 29228571
  20. 20

    Hereditary spherocytosis concomitant with JAK2V617F-positive primary myelofibrosis: a case report.

    Qiu CE, Lei L, Jiang G, et al.

    Frontiers in oncology 2025; (15()):1665179 doi:10.3389/fonc.2025.1665179.

    PMID: 41179685
  21. 21

    Subtotal Splenectomy in Hereditary Spherocytosis - Advantages and Disadvantages.

    Bică C, Cismaru L, Stănescu L, et al.

    Current health sciences journal 2016; (42(4)):408-412 doi:10.12865/CHSJ.42.04.11.

    PMID: 30581596
  22. 22

    A family affair-Severe fetal and neonatal hemolytic anemia due to novel alpha-spectrin mutations in two siblings.

    Donepudi R, Westerfield L, Stonecipher A, et al.

    American journal of medical genetics. Part A 2020; (182(3)):561-564 doi:10.1002/ajmg.a.61455.

    PMID: 31854503
  23. 23

    Identification of variants in 94 Chinese patients with hereditary spherocytosis by next-generation sequencing.

    Wang WJ, Xie JD, Yao H, et al.

    Clinical genetics 2023; (103(1)):67-78 doi:10.1111/cge.14244.

    PMID: 36203343

This page explains the biology and genetics of hereditary spherocytosis for educational purposes only. Always consult your hematologist or healthcare provider for specific medical advice and symptom management.

Stay up to date

Get notified when new research about Hereditary spherocytosis is published.

No spam. Unsubscribe anytime.